Supreme Court Blocks Generic Drug Liability Lawsuits


In a 5-4 vote, the U.S. Supreme Court ruled on Monday that drug makers cannot be sued under state law for adverse reactions to generic drugs. In writing the majority opinion, Justice Samuel Alito said that state laws cannot run against federal laws when drugs have been approved by the FDA. “Today’s court decision provides a disincentive for generic makers of drugs to monitor safety of their products and to make sure that they have a surveillance system in place to detect adverse events that pose a threat to patients,” said Michael Carome, director of Public Citizen’s Health Research Group.

Article →

Further interest:
Supreme Court rules Drug Companies exempt from Lawsuits (Whiteout Press)

Previous articleAttitudes Toward Psych Treatment Improves, Attitudes Toward People With Schizophrenia Worsens
Next articleADHD Drug Studies Find Little Change in Academic Performance
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].